Jeffrey Wang
Impact in
- Virology top 0.5%
- HIV Research and Treatment
- Infectious Diseases top 2%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
Papers in
- Oncology 5
- PARP inhibition in cancer therapy 4
-
- HIV/AIDS drug development and treatment 2
- Co-authors
- Ya‐Chi Ho (1 shared paper)Jun Lai (1 shared paper)Nina N. Hosmane (1 shared paper)Liang Shan (1 shared paper)Janet D. Siliciano (1 shared paper)Robert F. Siliciano (1 shared paper)Sarah B. Laskey (1 shared paper)Joel N. Blankson (1 shared paper)
- Journals
- Journal of Translational Medicine (3 papers)Journal of the American College of Radiology (1 paper)Expert Opinion on Drug Metabolism & Toxicology (1 paper)The FASEB Journal (1 paper)Journal of Biological Chemistry (1 paper)
- Partner nations
- United StatesEgyptSpain
In The Last Decade
Jeffrey Wang
14 papers receiving 1.3k citations
Jeffrey Wang's Hit Papers
Peers
Comparison fields: 5 of 75
- Virology 909
- Infectious Diseases 526
- Immunology 321
- Emergency Medicine 49
- Epidemiology 167
Countries citing papers authored by Jeffrey Wang
This map shows the geographic impact of Jeffrey Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey Wang more than expected).
Fields of papers citing papers by Jeffrey Wang
This network shows the impact of papers produced by Jeffrey Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey Wang. The network helps show where Jeffrey Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Jeffrey Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Replication-Competent Noninduced Proviruses in the Latent Reservoir Increase Barrier to HIV-1 Cure Hit paper breakdown → | 2013 | 1026 |
| 2 | 2012 | 57 | |
| 3 | 2015 | 44 | |
| 4 | 2015 | 34 | |
| 5 | 2009 | 30 | |
| 6 | 2009 | 26 | |
| 7 | 2005 | 25 | |
| 8 | 2011 | 17 | |
| 9 | 2022 | 17 | |
| 10 | 2008 | 17 | |
| 11 | 2019 | 16 | |
| 12 | 2018 | 13 | |
| 13 | 2022 | 3 | |
| 14 | 2016 | 1 |
About Jeffrey Wang
Jeffrey Wang is a scholar working on Oncology, Infectious Diseases, Surgery, Immunology and Molecular Biology, having authored 14 papers that have together received 1.3k indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (4 papers), HIV/AIDS drug development and treatment (2 papers), Immune Cell Function and Interaction (2 papers), DNA Repair Mechanisms (1 paper), Toxin Mechanisms and Immunotoxins (1 paper), Mitochondrial Function and Pathology (1 paper), Pancreatitis Pathology and Treatment (1 paper) and Genetic Neurodegenerative Diseases (1 paper). The work is most often cited by research in Virology (909 citations), Infectious Diseases (526 citations), Immunology (321 citations), Emergency Medicine (49 citations) and Epidemiology (167 citations). Jeffrey Wang has collaborated with scholars based in United States, Egypt and Spain. Frequent co-authors include Ya‐Chi Ho, Jun Lai, Nina N. Hosmane, Liang Shan, Janet D. Siliciano, Robert F. Siliciano, Sarah B. Laskey, Joel N. Blankson, Daniel I. S. Rosenbloom and Scott Ditch. Their work appears in journals such as Journal of Translational Medicine, Journal of the American College of Radiology, Expert Opinion on Drug Metabolism & Toxicology, The FASEB Journal and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.